Article Text

Download PDFPDF
Original article
Thyroid hormone resistance syndrome due to mutations in the thyroid hormone receptor α gene (THRA)
  1. Anna Tylki-Szymańska1,
  2. Rocio Acuna-Hidalgo2,
  3. Małgorzata Krajewska-Walasek3,
  4. Agnieszka Lecka-Ambroziak4,
  5. Marloes Steehouwer2,
  6. Christian Gilissen2,
  7. Han G Brunner2,
  8. Agnieszka Jurecka1,
  9. Agnieszka Różdżyńska-Świątkowska5,
  10. Alexander Hoischen2,
  11. Krystyna H Chrzanowska3
  1. 1Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland
  2. 2Department of Human Genetics, Radboud University Medical Center, Radboud Institute of Molecular Life Sciences, Nijmegen, The Netherlands
  3. 3Department of Clinical Genetics, The Children's Memorial Health Institute, Warsaw, Poland
  4. 4Department of Endocrinology and Diabetology, The Children's Memorial Health Institute, Warsaw, Poland
  5. 5Anthropology Laboratory, The Children's Memorial Health Institute, Warsaw, Poland
  1. Correspondence to Professor Anna Tylki-Szymańska at Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, Warsaw 04-730, Poland; atylki{at}


Background Resistance to thyroid hormone is characterised by a lack of response of peripheral tissues to the active form of thyroid hormone (triiodothyronine, T3). In about 85% of cases, a mutation in THRB, the gene coding for thyroid receptor β (TRβ), is the cause of this disorder. Recently, individual reports described the first patients with thyroid hormone receptor α gene (THRA) defects.

Methods We used longitudinal clinical assessments over a period of 18 years at one hospital setting combined with biochemical and molecular studies to characterise a novel thyroid hormone resistance syndrome in a cohort of six patients from five families.

Findings Using whole exome sequencing and subsequent Sanger sequencing, we identified truncating and missense mutations in the THRA gene in five of six individuals and describe a distinct and consistent phenotype of mild hypothyroidism (growth retardation, relatively high birth length and weight, mild-to-moderate mental retardation, mild skeletal dysplasia and constipation), specific facial features (round, somewhat coarse and flat face) and macrocephaly. Laboratory investigations revealed anaemia and slightly elevated cholesterol, while the thyroid profile showed low free thyroxine (fT4) levels coupled with high free T3 (fT3), leading to an altered T4 : T3 ratio, along with normal thyroid-stimulating hormone levels. We observed a genotype–phenotype correlation, with milder outcomes for missense mutations and more severe phenotypical effects for truncating mutations.

Interpretation THRA mutations may be more common than expected. In patients with clinical symptoms of mild hypothyreosis without confirmation in endocrine studies, a molecular study of THRA defects is strongly recommended.

  • thyroid hormone resistance syndrome
  • thyroid receptor
  • thyroid hormone receptor alpha gene

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.